Partnering opportunities

Biomarker companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop biomarker technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

4 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ | number }]} opportunities

4 opportunities

Get updates to this list Embed these results

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ }]}

First biomarker test for the diagnosis of osteoarthritis

-4 in order to strengthen significance of diagnosis (Table 1). Thus the present invention is the first serum biomarker test that helps to support the clinical diagnosis of OA. The university offers a license... more


Biomarker for efficient prediction and monitoring of tumor necrosis factor alpha in inflammation inhibition therapies

effects and high costs associated to TNF-alpha-blockers treatment. A German research group has generated positive data on the novel use of interleukin-22 binding protein (IL-22BP) as biomarker for the prediction... more


A comprehensive platform for contract research laboratory services bundled with cutting-edge bioinformatics for cancer drug efficacy screening, biomarker discovery and patient stratification

ATCC (American Type Culture Collection) and proprietary cell lines offer a wide variety to design the ideal drug screening experiments. Biomarker analytics - The platform offers 300+ multi-omic analytics workflows... more

United Kingdom

Early classification of aggressive prostate cancers

is a correlation with the risk for metastasis and the Gleason score, however there is an ongoing search for new biomarkers that directly correlate with the risk for metastasis. A German university discovered vimentin 3 (Vim3) as biomarker more


The right partner not here?

Get in touch and we'll help you post a partnering opportunity